Vildagliptin Dehydro Diketo Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Vildagliptin Dehydro Diketo Impurity

● Failure Report Available

Catalogue No.:VE0020392
CAS No.:N/A
Mol. Formula:C17H22N2O3
Mol. Weight:302.4 g/mol

Additional information on Vildagliptin Dehydro diketo impurity

Parent drug

Vildagliptin

IUPAC Name

2-(3-Hydroxyadamantan-1-yl)-1-oxo-2,6,7,8-tetrahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-4-olate

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

[O-]C1=CN(C23CC4(O)CC(C3)CC(C4)C2)C(C5=[N+]1CCC5)=O

InChI

InChI=1S/C17H22N2O3/c20-14-9-19(15(21)13-2-1-3-18(13)14)16-5-11-4-12(6-16)8-17(22,7-11)10-16/h9,11-12,22H,1-8,10H2

Description

Vildagliptin dehydro diketo impurity is a dehydration-derived degradation product observed during synthesis and accelerated stability studies of vildagliptin. This polar impurity exhibits a diketo motif with an unsaturated bond formed by loss of hydrogen and likely arises from intramolecular dehydration under acidic or thermal conditions. Analytical characterization requires orthogonal methods such as gradient reversed-phase HPLC for quantification, high-resolution LC-MS for accurate mass confirmation, and 1H and 13C NMR for structural elucidation. Its presence can affect impurity profiling, specification setting, and control strategy development, prompting forced-degradation experiments and targeted cleanup steps to minimize formation during process development.

Vildagliptin-Dehydro-Diketo-Impurity: Synthesis Attempts and Failure Report (NAP Test)

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url